A Controlled Trial of Abreaction with Lysergic Acid Diethylamide (Lsd-25)
J. Robinson, Lyndon Davies, E. L. N. S. Sack, Jean Morrissey
The British Journal of Psychiatry January 1, 1963 DOI: 10.1192/bjp.109.458.46 via OpenAlex
Summary
AI-generated from the abstractLysergic acid diethylamide (LSD-25) is described as a valuable aid to psychotherapy, acting as a deep abreactive agent that can erupt early traumatic experiences from infancy, accompanied by emotional catharsis believed to provide therapeutic benefit. It is also claimed to facilitate and enhance the transference situation between patient and therapist.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | Lysergic acid diethylamide (LSD-25) |
| Topics | LSD |
| Keywords | Catharsis Psychology Psychotherapist Psychoanalysis |
| Citations | 18 |
| Key finding | LSD-25 is acclaimed as a valuable aid to psychotherapy, erupting early traumatic experiences with emotional catharsis and enhancing the transference situation. |
Abstract
All who have used lysergic acid diethylamide (LSD-25) acclaim it as a valuable aid to psychotherapy, regarding it as a “deep” abreactive agent, in that in certain cases it erupts early traumatic experiences as far back as infancy, with appropriate emotional catharsis which is believed to be of considerable therapeutic benefit to the patient. It is also claimed that it facilitates and enhances the transference situation.